| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4899854e8f2fe2f8f0119cd2513e746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_007f229aff41f42cf667aa0e331093c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_314228f0c46a124bdbdde2679aafc05e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b475c4ba19892691797e2de72504b5c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db87b9c0cd54e9190f5f3c54667a6f51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c3835c61fb1b2941a814b4d373f8c56 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-60 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-78 |
| filingDate |
2010-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfaacdc7d3a2ed17bf520bee6dcfa3e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e873611271dff0627acbc6127b44b9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1a69e8bcce94120fb43e9da8497e9bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4229a46a6ef0b44bec18a3424dc67788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9172c1f939b2b9ee42113f3e0686884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff468b34990404acc9fed8f8955e645e |
| publicationDate |
2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2012231484-A1 |
| titleOfInvention |
Method and marker for determination degree of risk of onset of high-functioning autism |
| abstract |
The present invention relates to a method for determining the degree of risk of onset of autism, comprising the step of measuring the triglyceride concentration or the cholesterol concentration in a very low-density lipoprotein fraction of plasma or serum isolated from a subject, or the triglyceride concentration or the cholesterol concentration of plasma or serum. In addition, the present invention provides a kit for determining the degree of risk of onset of autism and a method for screening for a candidate substance for agents for treating autism using a non-human mammal, in which the above described method is utilized. |
| priorityDate |
2009-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |